Concepedia
Statistics
Publications
15
Citations
2K
H-Index
Active since
1987
Affiliations
Boehringer Ingelheim (Germany)(Current)
University of Applied Sciences Biberach
Pharmazeutische Fabrik Dr. Reckeweg (Germany)
Wolfgang Eberlein is an author at Boehringer Ingelheim (Germany) specializing in pharmacology, medicine, and molecular pharmacology.
Top concepts
MedicinePharmacologyDrug DiscoveryMolecular PharmacologyBiochemistryPharmacotherapyNatural SciencesNeuropharmacologyMedicinal ChemistryPhysiology
Publications per year
1987–2005
Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
Henri Doods, Gerhard Hallermayer, Dongmei Wu et al. · British Journal of Pharmacology · 2000 · 467 citations · Full text
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226
K Rudolf, Wolfgang Eberlein, Wolfhard Engel et al. · European Journal of Pharmacology · 1994 · 374 citations
Functional Selectivity, Medicine, G Protein-coupled Receptor +7
Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents
H. Wieland, W. Engel, Wolfgang Eberlein et al. · British Journal of Pharmacology · 1998 · 257 citations · Full text
BIIE0246: A selective and high affinity neuropeptide Y Y2 receptor antagonist
Henri Doods, Wolfram Gaida, H. Wieland et al. · European Journal of Pharmacology · 1999 · 189 citations
Molecular Pharmacology, Functional Selectivity, Medicine +8
Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
Henri Doods, Wolfgang Wienen, Michael Entzeroth et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 127 citations
1–5 of 15